ELVAF
Price
$0.90
Change
-$0.05 (-5.26%)
Updated
Nov 8 closing price
Capitalization
8.56M
NRSN
Price
$0.97
Change
-$0.02 (-2.02%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
22.53M
50 days until earnings call
Ad is loading...

ELVAF vs NRSN

Header iconELVAF vs NRSN Comparison
Open Charts ELVAF vs NRSNBanner chart's image
Evolva Holding AG
Price$0.90
Change-$0.05 (-5.26%)
Volume$194
Capitalization8.56M
NeuroSense Therapeutics
Price$0.97
Change-$0.02 (-2.02%)
Volume$200
Capitalization22.53M
ELVAF vs NRSN Comparison Chart
Loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVAF vs. NRSN commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVAF is a Hold and NRSN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (ELVAF: $0.90 vs. NRSN: $0.99)
Brand notoriety: ELVAF and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVAF: 100% vs. NRSN: 108%
Market capitalization -- ELVAF: $9.21M vs. NRSN: $22.53M
ELVAF [@Biotechnology] is valued at $9.21M. NRSN’s [@Biotechnology] market capitalization is $22.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVAF’s FA Score shows that 1 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • ELVAF’s FA Score: 1 green, 4 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVAF is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 4 TA indicator(s) are bullish.

  • NRSN’s TA Score: 4 bullish, 6 bearish.

Price Growth

ELVAF (@Biotechnology) experienced а 0.00% price change this week, while NRSN (@Biotechnology) price change was -0.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.36%. For the same industry, the average monthly price growth was -17.88%, and the average quarterly price growth was -17.48%.

Reported Earning Dates

NRSN is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-9.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($22.5M) has a higher market cap than ELVAF($8.56M). ELVAF YTD gains are higher at: 0.000 vs. NRSN (-17.500). ELVAF has higher annual earnings (EBITDA): 1.05M vs. NRSN (-10.41M). ELVAF has more cash in the bank: 6.75M vs. NRSN (344K). ELVAF (0) and NRSN (0) have equivalent revenues.
ELVAFNRSNELVAF / NRSN
Capitalization8.56M22.5M38%
EBITDA1.05M-10.41M-10%
Gain YTD0.000-17.500-
P/E RatioN/AN/A-
Revenue00-
Total Cash6.75M344K1,963%
Total DebtN/A19K-
FUNDAMENTALS RATINGS
ELVAF: Fundamental Ratings
ELVAF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
70
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRSN
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QSMLX14.62-0.59
-3.88%
AQR Small Cap Multi-Style I
CIPIX20.55-1.16
-5.34%
Champlain Mid Cap Institutional
HSCCX2.12-0.12
-5.36%
Carillon Eagle Small Cap Growth C
RWEBX55.79-3.44
-5.81%
American Funds Washington Mutual R2E
CCCAX5.89-0.58
-8.96%
Center Coast Brookfield Midstream Foc A

ELVAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVAF has been loosely correlated with REPL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVAF jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVAF
1D Price
Change %
ELVAF100%
N/A
REPL - ELVAF
60%
Loosely correlated
N/A
CLYYF - ELVAF
47%
Loosely correlated
N/A
IBIO - ELVAF
39%
Loosely correlated
-15.13%
GLABF - ELVAF
34%
Loosely correlated
N/A
NRSN - ELVAF
24%
Poorly correlated
+4.49%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+4.49%
SLRX - NRSN
32%
Poorly correlated
-4.31%
CTMX - NRSN
31%
Poorly correlated
-16.11%
DNLI - NRSN
29%
Poorly correlated
-7.90%
VKTX - NRSN
27%
Poorly correlated
-6.61%
KANT - NRSN
27%
Poorly correlated
N/A
More